Blog Listing

April 21 newsletter

EVIDENCE BASED TRADING – Dr. James C Krider

April 21, 2017, momentum stock universe.

4-21-17 Dr Krider performance

Dr. Krider’s managed portfolio YTD performance is 10.76% compared to the S&P 500’s 5.54%. This includes option trades.

Dr. James Krider creates monthly stock lists consisting of quality momentum stocks with associated weekly options. For each stock a stop loss and maximum position size is calculated. Stocks are entered and managed with options. For stocks we wish to own or control, we purchase a call at or near the stop loss and with an expiration of 3 months. Our excess cash is put to work selling PUTs for cash on a one to two-week basis with a minimum annualized gain of 20%. To view the currently active portfolios, go to Dr. Krider’s momentum stock universe. It is completely free and updated weekly.

To follow the actual and pending trades, subscribe to our premium service which includes both the portfolio and option trades.

Disclosure: I am long in AAPL, ABX, ACAD, AMAT, ANTM, ARCC, AVGO, BAC, BX, CHTR, CIEN, DIS, DOW, ETN, FB, GLW, JD, LRCX, MO, MU, NVDA, OLN, ORN, SPY, STMP, TMUS, TOL, V, VMW, WDC, and X.  I hold option positions In AVGO, BA, CC, DIS, DOW, EBAY, JD, MU, STMP, TMUS, TXN, WDC and X.

MARKET REVIEW        

Three-month chart: We continue at the bottom of the regression channel which is flattening. Neither the moving average slope, the rate of change or RSquared is significant for momentum.

4-21-17 3 month spy

One-month chart: The SPY continues trading at the moving average. The regression channel is down sloping and the moving average slope is negative.

4-21-17 one month spy

Technical analysis is bearish for short- and intermediate-term and remains bullish for the long-term timeframe.

Overall: The market is flat to bearish. We will play the market neutral.

NEXT WEEKS PLAN

I currently have 11 stocks which assigned from sold PUTs. I will be placing tight covered calls on all of them in order to minimize my exposure and maximize earned income. I have 32 momentum stocks in my option list. Any stocks moving positively against the market I will buy deep in the money calls near the stop loss level with a 2- to 3-month holding period.

The premium service has all my option trades that you can follow in real time.

For high net-worth investors Dr. Krider can personally manage your portfolio. Contact Dr. Krider at 760-242-1234 for more information.

Happy trading,

Dr. James Krider MD

 

 

 

 

 

James Krider, MD

Dr. James C Krider is a practicing family physician in Apple Valley, CA.

Dr. James C Krider is an Investment Advisor Representative licensed in the state of Nevada and is President of Krider Wealth Management, an Investment Advisory corporation based in Nevada.

These comments were prepared by James Krider, MD, an investment advisor representative of Krider Wealth Management, LLC, a Nevada state registered investment advisor. The information herein was obtained from various sources believed to be reliable; however, we do not guarantee its accuracy or completeness. The information in this report is given as of the date indicated. We assume no obligation to update this information, or advise on further developments relating to securities discussed in this report. Opinions expressed are subject to change without notice. Opinions of individual representatives may not be those of the Firm. Additional information is available upon request. The information contained in this document is prepared for general circulation and is circulated for general information only. It does not address specific investment objectives, or the financial situation and the particular needs of any recipient. Investors should not attempt to make investment decisions solely based on the information contained in this communication as it does not offer enough information to make such decisions and may not be suitable for your personal financial circumstances. You should consult with your financial professional prior to making such decisions. PAST PERFORMANCE SHOULD NOT BE CONSIDERED INDICATIVE OF FUTURE PERFORMANCE. ANY INVESTMENT CONTAINS RISK INCLUDING THE RISK OF TOTAL LOSS. This document does not constitute an offer, or an invitation to make an offer, to buy or sell any securities discussed herein.

 



Leave a Reply